Prescient is an evidence-based decision-support partner to the pharmaceutical and biotech industries whose mission is to optimally shape new product, brand and mature product planning strategies.

Our diverse yet integrated skillsets and methodologies ensure our clients’ key decisions are objectively assessed from both a clinical and commercial perspective, resulting in differentiated products and offerings.

 

Shaping Decisions Driving Value

Our People

Prescient’s team consists of highly experienced executives who share our core values of thinking collaboratively, creatively and constructively. We effectively integrate different skills and perspectives into a single client-engagement team.

Our Approach

The format and scope of our engagements are customized to meet our clients’ needs and our ‘best-in-front’ team philosophy ensures access to the necessary levels of expertise and thinking.

Our Clients

We engage directly with a number of functions supporting new product, brand and mature product planning activities; to view a full list of these, please click the
link below.

Latest News

Ready. Raise. Rise. Campaign

Why are women less likely to be prescribed statins than men?

Research points to a new treatment for pancreatic cancer

A faster and cheaper way to produce new antibiotics

UCB, Teva, Novartis, Pfizer and TransCelerate Biopharma win industry recognition at the eyeforpharma …

Pfizer reports first-quarter 2016 results

New cancer drugs could treat lethal resistant prostate cancers

Researchers discover potential treatment for sepsis and other responses to infection

Bristol-Myers Squibb reports first quarter financial results

One family's history of the rare condition Fabry disease through the generations

'Mediterranean' diet linked to lower risk of heart attacks & strokes in heart patients

What's the secret to living a full life? A new global survey reveals family comes first

Bayer off to a successful start in 2016

Merck brings international start-up-companies to Darmstadt and Nairobi

2016 Otto Bayer Award goes to Professor Dr. Dirk Trauner

Error: Feed has an error or is not valid

WAVE Life Sciences inks deal worth more than $900 million with Pfizer on metabolic diseases

NZ$124 million hike over four years for investment in new medicines in New Zealand

NICE recommends Humira as the first approved treatment for skin condition HD

Bioscience division drives sales growth at Grifols

APAC's non-small cell lung cancer market to hit $4.9 billion by 2022, report predicts

Praluent and Repatha recommended by NICE for cholesterol disorder

UK's early access to medicines scheme 'not fit for purpose'

Merck & Co’s 1st-qtr revenues hit by generic competition

Recordati rises across 1st-qtr financial results

AMRI to acquire Italian API maker for $358 million

Minister calls for patient voice to be heard

Cellular immunotherapies represent long-term opportunity

Regeneron reaping profits of eye disease treatment, 1st qtr figures show

European priority medicines scheme attracts 18 applications in first month

European approval for Eisai’s Halaven for advanced liposarcoma

Medical News Today: My baby is imitating me…or is she?

Medical News Today: Bipolar, autism, and schizophrenia might share genetic origin

Medical News Today: Warfarin use for atrial fibrillation increases dementia risk

Medical News Today: Poor fetal, maternal outcomes linked to high-fructose diet in pregnancy

Medical News Today: Vitamin D supplementation among infants boosts muscle mass at 3 years

Medical News Today: Schizophrenia, bipolar tied to yeast infection

Medical News Today: ALS may arise from protein build-up in nerve cells

Medical News Today: What are the Health Benefits of Walnuts?

Medical News Today: Medical error 'causes more than 250,000 deaths in the U.S. annually'

Medical News Today: Wired Health: Innovations within our reach

Medical News Today: Antibiotics can promote 'bad' gut microbes by disrupting oxygen

Medical News Today: Early respiratory tract infections may raise children's type 1 diabetes ris …

Medical News Today: Antibiotic use in America: 30 percent of prescriptions 'inappropriate'

Medical News Today: Why do Labrador retrievers love food so much?

Medical News Today: Personalized breast cancer treatment steps closer with gene discovery

GPs grappling with a greater, more complex workload, finds report

NICE backs Sanofi's Praluent' Amgen's Repatha for cholesterol disorder

Pfizer, Wave sign $900m metabolic diseases pact

Sanofi threatens hostile bid for Medivation

Hunt offers to pause junior contract imposition to allow talks

Google accessing 1.6 million NHS patient records

NICE allows more time for Duchenne drug access plan

EU nod for Eisai's Halaven in liposarcoma

Priority review for Lilly's soft tissue sarcoma drug

Bayer's regorafenib improves survival in liver cancer patients

More News